1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	HIV-1	HIV-1	_	_	_	_	_	_	_
4	latency	latency	_	_	_	_	_	_	_
5	reactivation	reactivation	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	dehydroepiandrosterone	dehydroepiandrosterone	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	DHEA	DHEA	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	an	an	_	_	_	_	_	_	_
13	analog	analog	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	DHEA	DHEA	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	initial	initial	_	_	_	_	_	_	_
3	infection	infection	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
7	virus	virus	_	_	_	_	_	_	_
8	type	type	_	_	_	_	_	_	_
9	1	1	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	HIV-1	HIV-1	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	most	most	_	_	_	_	_	_	_
15	individuals	individual	_	_	_	_	_	_	_
16	usually	usually	_	_	_	_	_	_	_
17	results	result	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	establishment	establishment	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	latent	latent	_	_	_	_	_	_	_
24	or	or	_	_	_	_	_	_	_
25	chronic	chronic	_	_	_	_	_	_	_
26	infection	infection	_	_	_	_	_	_	_
27	before	before	_	_	_	_	_	_	_
28	eventual	eventual	_	_	_	_	_	_	_
29	progression	progression	_	_	_	_	_	_	_
30	toward	toward	_	_	_	_	_	_	_
31	acquired	acquire	_	_	_	_	_	_	_
32	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
33	syndrome	syndrome	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	HIV-1	HIV-1	_	_	_	_	_	_	_
2	can	can	_	_	_	_	_	_	_
3	also	also	_	_	_	_	_	_	_
4	establish	establish	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	latent	latent	_	_	_	_	_	_	_
7	or	or	_	_	_	_	_	_	_
8	persistent	persistent	_	_	_	_	_	_	_
9	infection	infection	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	some	some	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	lines	line	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	show	show	_	_	_	_	_	_	_
17	minimal	minimal	_	_	_	_	_	_	_
18	constitutive	constitutive	_	_	_	_	_	_	_
19	virus	virus	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	lines	line	_	_	_	_	_	_	_
9	leading	lead	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	enhanced	enhance	_	_	_	_	_	_	_
12	HIV-1	HIV-1	_	_	_	_	_	_	_
13	replication	replication	_	_	_	_	_	_	_
14	can	can	_	_	_	_	_	_	_
15	be	be	_	_	_	_	_	_	_
16	induced	induce	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	antigens	antigen	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	mitogens	mitogen	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	cytokines	cytokine	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	tumor	tumor	_	_	_	_	_	_	_
26	necrosis	necrosis	_	_	_	_	_	_	_
27	factor	factor	_	_	_	_	_	_	_
28	alpha	alpha	_	_	_	_	_	_	_
29	[	[	_	_	_	_	_	_	_
30	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
31	]	]	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	interleukin	interleukin	_	_	_	_	_	_	_
34	1	1	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	interleukin-2	interleukin-2	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Various	various	_	_	_	_	_	_	_
2	gene	gene	_	_	_	_	_	_	_
3	products	product	_	_	_	_	_	_	_
4	from	from	_	_	_	_	_	_	_
5	other	other	_	_	_	_	_	_	_
6	viruses	virus	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	HTLV-1	HTLV-1	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	HSV	HSV	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	EBV	EBV	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	CMV	CMV	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	HBV	HBV	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	HHV-6	HHV-6	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	can	can	_	_	_	_	_	_	_
22	also	also	_	_	_	_	_	_	_
23	enhance	enhance	_	_	_	_	_	_	_
24	HIV-1	HIV-1	_	_	_	_	_	_	_
25	long	long	_	_	_	_	_	_	_
26	terminal	terminal	_	_	_	_	_	_	_
27	repeat	repeat	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	LTR)-driven	ltr)-driven	_	_	_	_	_	_	_
30	reporter	reporter	_	_	_	_	_	_	_
31	gene	gene	_	_	_	_	_	_	_
32	activity	activity	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	On	on	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	basis	basis	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	these	these	_	_	_	_	_	_	_
6	observations	observation	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	it	it	_	_	_	_	_	_	_
9	has	have	_	_	_	_	_	_	_
10	been	be	_	_	_	_	_	_	_
11	proposed	propose	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	reactivation	reactivation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	latent	latent	_	_	_	_	_	_	_
16	HIV-1	HIV-1	_	_	_	_	_	_	_
17	harbored	harbor	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	chronically	chronically	_	_	_	_	_	_	_
20	infected	infected	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	lymphocytes	lymphocyte	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	monocytes	monocyte	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	or	or	_	_	_	_	_	_	_
27	macrophages	macrophage	_	_	_	_	_	_	_
28	plays	play	_	_	_	_	_	_	_
29	an	an	_	_	_	_	_	_	_
30	important	important	_	_	_	_	_	_	_
31	role	role	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	pathogenesis	pathogenesis	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	AIDS	AIDS	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	So	so	_	_	_	_	_	_	_
2	far	far	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	there	there	_	_	_	_	_	_	_
5	are	be	_	_	_	_	_	_	_
6	no	no	_	_	_	_	_	_	_
7	drugs	drug	_	_	_	_	_	_	_
8	or	or	_	_	_	_	_	_	_
9	therapy	therapy	_	_	_	_	_	_	_
10	available	available	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	can	can	_	_	_	_	_	_	_
13	provide	provide	_	_	_	_	_	_	_
14	protection	protection	_	_	_	_	_	_	_
15	against	against	_	_	_	_	_	_	_
16	HIV-1	HIV-1	_	_	_	_	_	_	_
17	latency	latency	_	_	_	_	_	_	_
18	reactivation	reactivation	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	ACH-2	ach-2	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	derived	derive	_	_	_	_	_	_	_
4	from	from	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	line	line	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	CEM	CEM	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	chronically	chronically	_	_	_	_	_	_	_
16	infected	infect	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	HIV-1	HIV-1	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	low	low	_	_	_	_	_	_	_
22	levels	level	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	constitutive	constitutive	_	_	_	_	_	_	_
25	virus	virus	_	_	_	_	_	_	_
26	expression	expression	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	ACH-2	ach-2	_	_	_	_	_	_	_
2	can	can	_	_	_	_	_	_	_
3	be	be	_	_	_	_	_	_	_
4	converted	convert	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	productive	productive	_	_	_	_	_	_	_
7	infection	infection	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	stimulation	stimulation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	TPA	TPA	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	mitogen	mitogen	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	cytokines	cytokine	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	or	or	_	_	_	_	_	_	_
27	infection	infection	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	HSV	HSV	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Therefore	therefore	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	ACH-2	ach-2	_	_	_	_	_	_	_
4	cell	cell	_	_	_	_	_	_	_
5	line	line	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	good	good	_	_	_	_	_	_	_
9	candidate	candidate	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	studying	study	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	effects	effect	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	drugs	drug	_	_	_	_	_	_	_
16	on	on	_	_	_	_	_	_	_
17	HIV-1	HIV-1	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Previously	previously	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	have	have	_	_	_	_	_	_	_
5	reported	report	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	DHEA	DHEA	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	synthetic	synthetic	_	_	_	_	_	_	_
10	analogs	analog	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	DHEA	DHEA	_	_	_	_	_	_	_
13	can	can	_	_	_	_	_	_	_
14	be	be	_	_	_	_	_	_	_
15	modest	modest	_	_	_	_	_	_	_
16	inhibitors	inhibitor	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	HIV-1	HIV-1	_	_	_	_	_	_	_
19	IIIB	IIIB	_	_	_	_	_	_	_
20	replication	replication	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	phytohemagglutinin-stimulated	phytohemagglutinin-stimulated	_	_	_	_	_	_	_
23	peripheral	peripheral	_	_	_	_	_	_	_
24	blood	blood	_	_	_	_	_	_	_
25	lymphocyte	lymphocyte	_	_	_	_	_	_	_
26	cultures	culture	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	(	(	_	_	_	_	_	_	_
2	ABSTRACT	abstract	_	_	_	_	_	_	_
3	TRUNCATED	truncated	_	_	_	_	_	_	_
4	AT	at	_	_	_	_	_	_	_
5	250	250	_	_	_	_	_	_	_
6	WORDS	words	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_

